Pharsight

ARENA PHARMACEUTICALS PATENTS FACING OPPOSITIONS

Top patents of ARENA PHARMACEUTICALS facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3860590B1 07 Jun, 2023 Methods For The Treatment Of Scleroderma NA 2
EP3310760B8 19 Oct, 2022 Crystalline L-Arginine Salt Of (R)-2-(7-(4-Cyclopentyl-3-(Trifluoromethyl)Benzyloxy)-1,2,3,4-Tetrahydrocyclo-Penta[B]Indol-3-Yl)Acetic Acid(Compound1) For Use In Sipi Receptor-Associated Disorders Jun, 2036 2